Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
71,344,848
-
Share change
-
+2,146,047
-
Total reported value
-
$5,443,126,189
-
Put/Call ratio
-
220%
-
Price per share
-
$76.25
-
Number of holders
-
401
-
Value change
-
+$152,715,865
-
Number of buys
-
158
-
Number of sells
-
200
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2019
As of 30 Sep 2019,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
401 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,344,848 shares.
The largest 10 holders included
BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, BARCLAYS PLC, UBS Group AG, WELLS FARGO & COMPANY/MN, and Clal Insurance Enterprises Holdings Ltd.
This page lists
401
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.